Skip to content
healthcare.dev

PHYRAGO

NDC 70709-153, dasatinib, tablet, from Cycle Pharmaceuticals Ltd.

Product NDC
70709-153
Status
Listed
Labeler
Cycle Pharmaceuticals Ltd
Dosage form
TABLET
Route
ORAL
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
NDA
Application
NDA216099
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/70709-153 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • DASATINIB70 mg/1

Pharmacologic classes

Cytochrome P450 3A4 Inhibitors [MoA]; Kinase Inhibitor [EPC]; Protein Kinase Inhibitors [MoA]

Package NDCNDC-11Package
70709-153-707070901537060 TABLET in 1 BOTTLE (70709-153-70)

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/60976d1e-c415-417f-8168-4e07999a7281

Use it

Look up 70709-153 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/70709-153 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 70709-153. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.